FMP
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
T14.SI
SES
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.
2.42 USD
0.03 (1.24%)
About
ceo
Ms. Lei Wang
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.zhongxinp.comexchange
SES
Description
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceut...
CIK
N/A
ISIN
CNE100000924
CUSIP
N/A
Address
Zhong Xin Mansion
Phone
86 22 2702 0892
Country
CN
Employee
4,619
IPO Date
Jan 3, 2000
Summary
CIK
-
Exchange
SES
Industry
Drug Manufacturers -...
Sector
Healthcare
CUSIP
-
ISIN
CNE100000924
Country
CN
Price
2.42
Beta
0.7
Volume Avg.
111.36k
Market Cap
3.94B
Shares
-
52-Week
1.66-2.66
DCF
2.47
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
14.24
P/B
-
Website
https://www.zhongxinp.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest T14.SI News
It looks like there's no news available.
